ClinicalTrials.Veeva

Menu

Plasma Oxalate in Patient With Short Bowel (OXAGO)

Civil Hospices of Lyon logo

Civil Hospices of Lyon

Status

Completed

Conditions

Hyperoxaluria
Short Bowel Syndrome
Hyperoxalemia

Treatments

Procedure: Pulse Wave Velocity (PWV) measurement
Biological: Blood sampling
Procedure: central pressure measurement
Biological: Urine sampling

Study type

Observational

Funder types

Other

Identifiers

NCT04119765
69HCL18_0408

Details and patient eligibility

About

Hyperoxaluria due to fat malabsorption is seen in patients suffering from short bowel and can lead to stones and nephrocalcinosis. Not all patients are prone to these renal complications. only urinary oxaluria is measured in practice. Plasma oxalate shouldn't increase theoretically in these patients. However recent report showed an increase of plasma oxalate in patient with enteric hyperoxaluria. The aim of this study is to assess the plasma oxalate distribution in this specific population to have a new tool to predict renal complication of these patients.

Enrollment

47 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age ≥ 18 years
  • Type II short bowel for more than 6 months
  • Affiliated to a social health care

Exclusion criteria

  • Primary hyperoxaluria
  • Other type of short bowel than type II
  • Minor patient or major patient protected by the law

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems